SCHEMBL6947484

SCHEMBL6947484

N#Cc1c(N2CCc3ccccc3CC2)nc(C2CC2)n(CC(F)(F)F)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 4/20 0.42
HPGD P15428 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GRM2 Q14416 5/20 0.38
HTT P42858 3/20 0.37
HSD17B10 Q99714 3/20 0.37
MAPT P10636 2/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MAPK1 P28482 1/20 0.35
KHK P50053 2/20 0.35
CXCR4 P61073 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947600 0.86 GRM2 (0.40) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6947710 0.82 KDM4E (0.38) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6950991 0.82 GRM2 (0.37) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6945569 0.80 ALDH1A1 (0.37) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6952941 0.77 KDM4E (0.35) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6954345 0.76 GRM2 (0.41) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6952709 0.75 GRM2 (0.42) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6949441 0.74 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6947753 0.74 GAA (0.41) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6949656 0.74 GRM2 (0.41) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed